A combination of demographic, market and technology trends is having a profound effect on the transformation of the healthcare sector. The increasing digitalisation of healthcare, emerging new technologies as well as business models, opens up new possibilities at the crossroad of space and health.  

The effects of microgravity on biological, chemical and physical processes enable both public and private actors to elevate their understanding of a broad range of diseases and to improve as well as develop new medicine treatments for humans on earth. In parallel satellites have historically had a strong impact on human and environmental health with its revelations on ozone depletion and more recently contributing to health issues related to climate, epidemiology and water/vector borne diseases. Telemedicine is enabling new forms of outpatient care by providing remote diagnosis, treatment and monitoring and enabling the emergence of digital platforms.  

For all these developments collaboration between institutions, research organisations, industry and investors within space and health will be key to enable a new wave of commercial solutions supporting both sectors.  

On the 19th of April, the ESA Commercialisation Gateway will therefore be organising its ESA Commercialisation Days event with the objective of bringing these key actors together as well as opening up to the public to attend. The event will be the first in its series focussing on health and biotech and held at the European Space Research and Technology Centre (ESTEC) in Noordwijk, the Netherlands.  

The event will take place in the Highbay of the Erasmus centre in ESTEC.